Medical Properties (MPW)
NYSE:MPW
Advertisement

Medical Properties (MPW) AI Stock Analysis

Compare
6,168 Followers

Top Page

MPW

Medical Properties

(NYSE:MPW)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 4o)
Rating:54Neutral
Price Target:
$5.50
▲(7.00% Upside)
The overall stock score is primarily influenced by the company's financial challenges, including declining revenue and high leverage. While technical indicators show some positive momentum, and the earnings call provided optimistic guidance, the negative P/E ratio and mixed earnings call results weigh heavily on the score. The high dividend yield offers some appeal, but significant risks remain.
Positive Factors
Business Model Strength
The triple-net lease model ensures stable rental income, as tenants cover property taxes, insurance, and maintenance, reducing operational risk.
Strategic Partnerships
Partnerships with top healthcare operators enhance occupancy and cash flow reliability, supporting long-term revenue stability and growth.
Share Repurchase Program
The share repurchase reflects management's confidence in the business model and can improve shareholder value by reducing share count.
Negative Factors
High Leverage
High leverage increases financial risk and limits flexibility, potentially impacting the company's ability to invest in growth opportunities.
Declining Revenue
Declining revenue trends indicate potential challenges in maintaining market position and could pressure profitability if not reversed.
Prospect Bankruptcy
The bankruptcy of a major tenant like Prospect can lead to financial impairments and uncertainty in cash flow, affecting overall stability.

Medical Properties (MPW) vs. SPDR S&P 500 ETF (SPY)

Medical Properties Business Overview & Revenue Model

Company DescriptionMedical Properties Trust, Inc. (MPW) is a real estate investment trust (REIT) that specializes in acquiring and managing healthcare facilities. The company focuses on investing in hospitals and other medical properties across the United States and internationally. MPW's portfolio includes a diverse range of healthcare facilities, primarily acute care hospitals, rehabilitation hospitals, and long-term care facilities, providing essential services to communities while generating stable rental income.
How the Company Makes MoneyMedical Properties Trust generates revenue primarily through long-term leases with healthcare operators. The company purchases healthcare facilities and then leases them back to operators under triple-net leases, meaning the tenants are responsible for property taxes, insurance, and maintenance costs. This revenue model provides MPW with a steady stream of rental income. Additionally, MPW benefits from rental escalations built into its leases, which can enhance revenue over time. The company's strategic partnerships with leading healthcare providers and operators also play a crucial role in its success, as they help secure high occupancy rates and reliable cash flow. Moreover, MPW's focus on acquiring properties in growing markets and its expertise in the healthcare sector contribute to its ability to generate consistent earnings.

Medical Properties Earnings Call Summary

Earnings Call Date:Oct 30, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 19, 2026
Earnings Call Sentiment Neutral
The earnings call reflected both strong tenant performance and strategic advancements, such as new lease agreements and a share repurchase program, but was also marked by significant impairments and delayed rent payments, indicating mixed results.
Q3-2025 Updates
Positive Updates
Strong Tenant Performance
General acute care operators reported a more than $200 million increase in EBITDARM year-over-year. Post-acute operators reported a $50 million EBITDARM increase, with Ernest Health up 17%, Vibra up 33%, and MEDIAN up 7%. Behavioral health portfolio EBITDARM increased by $10 million year-over-year.
New Lease Agreements and Settlements
NOR Healthcare Systems in California was named the successful bidder for Prospect's 6 California facilities. A new lease agreement was promptly agreed upon, with annual rent reaching $45 million.
Share Repurchase Program
The Board of Directors authorized a $150 million share repurchase program, reflecting confidence in the business model and belief that the share price is undervalued.
Record Performance in International Operations
International operators comprise approximately 50% of the total portfolio, with coverages exceeding 2x. Notably, Circle in the U.K. received high patient satisfaction rankings and significant investments in advanced technologies.
Strong Financial Metrics
Normalized FFO of $0.13 per share for the third quarter of 2025, with higher earnings from equity interests due to German tax policy changes and upward real estate adjustments.
Negative Updates
Prospect Bankruptcy and Asset Impairments
Net impairments of approximately $82 million were recorded, primarily related to Prospect and the decline in expected proceeds of certain Pennsylvania and Rhode Island assets.
Delayed Rent Payments
Payment of September rent by HSA was delayed until October 1, indicating potential cash flow timing concerns.
Operational Challenges in the U.S.
Summer seasonality drove softer volumes in the third quarter for HSA, and construction continues on facilities in Massachusetts and Texas with ongoing negotiations.
Company Guidance
During the Medical Properties Trust third quarter 2025 earnings call, several key financial metrics and operational updates were shared. General acute care operators reported a more than $200 million increase in EBITDARM year-over-year, with LifePoint Health and ScionHealth achieving double-digit revenue growth. Post-acute operators saw a $50 million increase, with notable improvements from Ernest Health, Vibra, and MEDIAN. The behavioral health portfolio also experienced a $10 million EBITDARM increase. The company reached a settlement with Yale New Haven and Prospect, with the latter set to receive $45 million, and they anticipate generating annualized cash rent of over $1 billion by the end of 2026. Additionally, the Board authorized a $150 million share repurchase program, reflecting confidence in the company's valuation. Normalized FFO was reported at $0.13 per share for the quarter, with a potential $0.01 increase if not for a delayed payment by HSA. Despite some challenges, including Prospect's bankruptcy, Medical Properties Trust remains optimistic about its portfolio's performance and strategic initiatives.

Medical Properties Financial Statement Overview

Summary
Medical Properties faces significant financial challenges, with declining revenue and profitability, high leverage, and cash flow management issues. While there are some strengths, such as positive operating cash flow, the overall financial health is concerning. The company needs to address its debt levels and improve operational efficiency to stabilize its financial position.
Income Statement
45
Neutral
Medical Properties shows declining revenue and profitability. The TTM revenue has decreased compared to the previous year, and the net income remains negative, indicating ongoing financial challenges. The gross profit margin is relatively high, but the net profit margin is negative due to significant net losses. EBIT and EBITDA margins have also deteriorated, reflecting operational inefficiencies.
Balance Sheet
50
Neutral
The balance sheet reveals a high debt-to-equity ratio, indicating significant leverage. The equity ratio has decreased over time, suggesting reduced financial stability. However, the company maintains a reasonable level of total assets, which provides some buffer against liabilities. The return on equity is negative due to net losses, highlighting profitability issues.
Cash Flow
55
Neutral
Operating cash flow is positive, but free cash flow has declined, indicating cash management challenges. The operating cash flow to net income ratio is favorable, suggesting that cash generation is better than reported earnings. However, the free cash flow to net income ratio is negative, reflecting insufficient cash to cover net losses.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue936.95M995.55M871.80M1.54B1.54B1.25B
Gross Profit766.57M968.29M830.23M1.50B1.51B1.22B
EBITDA699.12M840.60M697.41M1.35B1.37B1.10B
Net Income-707.43M-2.41B-556.48M902.60M656.02M431.45M
Balance Sheet
Total Assets14.92B14.29B18.30B19.66B20.52B16.83B
Cash, Cash Equivalents and Short-Term Investments396.58M332.33M250.02M235.67M459.23M549.88M
Total Debt9.76B8.98B10.22B10.41B11.37B9.01B
Total Liabilities10.26B9.46B10.67B11.06B12.07B9.49B
Stockholders Equity4.66B4.83B7.63B8.59B8.44B7.34B
Cash Flow
Free Cash Flow128.82M245.48M505.79M-801.35M746.11M-3.67B
Operating Cash Flow128.82M245.48M505.79M739.01M811.66M617.64M
Investing Cash Flow-70.00M1.32B517.56M396.06M-3.86B-2.95B
Financing Cash Flow171.72M-1.48B-1.02B-1.34B2.95B1.40B

Medical Properties Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5.14
Price Trends
50DMA
5.06
Positive
100DMA
4.62
Positive
200DMA
4.79
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
54.18
Neutral
STOCH
53.38
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MPW, the sentiment is Positive. The current price of 5.14 is above the 20-day moving average (MA) of 5.04, above the 50-day MA of 5.06, and above the 200-day MA of 4.79, indicating a bullish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 54.18 is Neutral, neither overbought nor oversold. The STOCH value of 53.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MPW.

Medical Properties Risk Analysis

Medical Properties disclosed 56 risk factors in its most recent earnings report. Medical Properties reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Medical Properties Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$8.01B26.738.13%3.56%59.25%88.37%
75
Outperform
$3.68B24.3210.87%4.81%8.04%9.20%
74
Outperform
$1.72B49.393.49%6.32%11.89%-68.41%
74
Outperform
$4.65B25.656.29%6.46%8.12%75.95%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
56
Neutral
$1.12B-18.84%0.86%4.10%8.96%
54
Neutral
$2.98B-14.02%6.46%45.56%73.44%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MPW
Medical Properties
5.14
1.21
30.79%
LTC
LTC Properties
36.07
0.39
1.09%
NHI
National Health Investors
77.85
4.40
5.99%
SBRA
Sabra Healthcare REIT
18.59
1.39
8.09%
DHC
Diversified Healthcare Trust
4.61
2.12
85.14%
CTRE
CareTrust REIT
36.38
7.39
25.49%

Medical Properties Corporate Events

Medical Properties Trust Reports Q3 2025 Results
Oct 31, 2025

Medical Properties Trust, Inc. is a real estate investment trust specializing in acquiring and developing net-leased hospital facilities, making it one of the largest owners of hospital real estate globally, with a portfolio spanning nine countries and three continents.

Business Operations and StrategyStock BuybackFinancial Disclosures
Medical Properties Announces $150 Million Stock Buyback
Neutral
Oct 30, 2025

On October 28, 2025, Medical Properties Trust, Inc. announced a $150 million stock repurchase program, reflecting strategic financial management amid ongoing operational adjustments. The company reported a third-quarter net loss of $78 million, influenced by impairment charges, but highlighted increased cash rent collections and strategic agreements, such as the lease with NOR Healthcare Systems Corp. for California operations. The company’s efforts to stabilize and enhance its portfolio, including settlements and asset sales, indicate a focus on liquidity and debt management, aiming for over $1 billion in annualized cash rent by the end of 2026.

The most recent analyst rating on (MPW) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Medical Properties stock, see the MPW Stock Forecast page.

Private Placements and Financing
Medical Properties Announces $500 Million Equity Agreement
Neutral
Aug 14, 2025

On August 11, 2025, Medical Properties entered into an equity distribution agreement with several financial institutions to offer and sell up to $500 million in common stock. This agreement allows for various types of transactions, including at-the-market offerings and forward sale transactions, with the company potentially receiving proceeds upon settlement. The company may choose different settlement options, which could impact the proceeds received.

The most recent analyst rating on (MPW) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Medical Properties stock, see the MPW Stock Forecast page.

Regulatory Filings and Compliance
Medical Properties Updates REIT Tax Considerations
Neutral
Aug 11, 2025

On June 2, 2025, Medical Properties, along with its subsidiaries, filed a Registration Statement with the SEC, updating the U.S. Federal Income Tax Considerations for its REIT status. The filing outlines the tax implications for the company and its stakeholders, emphasizing the benefits and potential liabilities associated with its REIT classification, including the avoidance of double taxation and the conditions under which it may incur federal taxes.

The most recent analyst rating on (MPW) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Medical Properties stock, see the MPW Stock Forecast page.

Medical Properties Trust Earnings Call: Growth Amid Challenges
Aug 2, 2025

The recent earnings call of Medical Properties Trust (MPT) presented a balanced outlook, highlighting significant successes alongside notable challenges. The company reported strong revenue growth and successful refinancing activities, particularly in Europe and with new U.S. tenants. However, it also faces challenges, including asset impairments linked to Prospect’s bankruptcy and operational issues in specific U.S. regions.

Medical Properties Trust Reports Q2 2025 Earnings
Aug 1, 2025

Medical Properties Trust, Inc. is a self-advised real estate investment trust specializing in acquiring and developing net-leased hospital facilities, with a global portfolio that includes 392 facilities across nine countries.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 31, 2025